Royal Bank of Canada’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.39M Buy
206,124
+23,288
+13% +$270K ﹤0.01% 2879
2025
Q1
$1.6M Buy
182,836
+162,665
+806% +$1.42M ﹤0.01% 2819
2024
Q4
$288K Buy
20,171
+2,189
+12% +$31.3K ﹤0.01% 4071
2024
Q3
$406K Buy
17,982
+3,399
+23% +$76.7K ﹤0.01% 3848
2024
Q2
$284K Sell
14,583
-11,519
-44% -$224K ﹤0.01% 4099
2024
Q1
$979K Buy
26,102
+2,325
+10% +$87.2K ﹤0.01% 3099
2023
Q4
$1.33M Buy
23,777
+11,135
+88% +$623K ﹤0.01% 2971
2023
Q3
$522K Buy
12,642
+1,594
+14% +$65.8K ﹤0.01% 3540
2023
Q2
$616K Sell
11,048
-1,680
-13% -$93.7K ﹤0.01% 3394
2023
Q1
$709K Sell
12,728
-13,142
-51% -$732K ﹤0.01% 3268
2022
Q4
$943K Sell
25,870
-7,737
-23% -$282K ﹤0.01% 3139
2022
Q3
$956K Sell
33,607
-18,050
-35% -$513K ﹤0.01% 3069
2022
Q2
$2.34M Buy
51,657
+4,708
+10% +$213K ﹤0.01% 2410
2022
Q1
$3.57M Sell
46,949
-2,346
-5% -$178K ﹤0.01% 2209
2021
Q4
$7.34M Buy
49,295
+17,341
+54% +$2.58M ﹤0.01% 1806
2021
Q3
$4.65M Buy
31,954
+1,019
+3% +$148K ﹤0.01% 2037
2021
Q2
$6.06M Buy
30,935
+795
+3% +$156K ﹤0.01% 1941
2021
Q1
$5.46M Buy
30,140
+11,850
+65% +$2.15M ﹤0.01% 1913
2020
Q4
$2.59M Buy
18,290
+10,384
+131% +$1.47M ﹤0.01% 2312
2020
Q3
$986K Buy
7,906
+5,954
+305% +$743K ﹤0.01% 2865
2020
Q2
$175K Buy
1,952
+702
+56% +$62.9K ﹤0.01% 4085
2020
Q1
$78K Sell
1,250
-2,459
-66% -$153K ﹤0.01% 4432
2019
Q4
$283K Buy
3,709
+3,626
+4,369% +$277K ﹤0.01% 3819
2019
Q3
$4K Buy
+83
New +$4K ﹤0.01% 5469